月経困難症治療の世界市場成長(現状と展望)2024-2030年Global Dysmenorrhea Treatment Market Growth (Status and Outlook) 2024-2030 LPI(LPインフォメーション)の最新調査によると、世界の月経困難症治療剤の市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、月経困難症治療薬はレビュー期間中のCAGR %で2030年... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーLPI(LPインフォメーション)の最新調査によると、世界の月経困難症治療剤の市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、月経困難症治療薬はレビュー期間中のCAGR %で2030年までに百万米ドルの再調整サイズになると予測されています。この調査レポートは、世界の月経困難症治療市場の成長可能性を明らかにしています。月経困難症治療薬は、今後の市場で安定した成長を示すと予想される。しかし、月経困難症治療薬の普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要です。市場参加者は、月経困難症治療薬市場がもたらす莫大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要があります。 月経困難症とは、痛みを伴う月経の一種を指す。 世界の医薬品市場は、2022年には1,475億米ドルとなり、今後6年間のCAGRは5%で成長する。医薬品市場には化学医薬品と生物学的製剤がある。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。 主な特徴 月経困難症治療薬市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、月経困難症治療市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(鎮痛剤、ホルモン療法など)、地域別内訳などが含まれます。 市場の促進要因と課題:当レポートでは、政府の規制、環境問題、技術の進歩、消費者の嗜好の変化など、月経困難症治療薬市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができます。 競合情勢:この調査レポートは、月経困難症治療市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれます。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。 技術開発:この調査レポートは、月経困難症治療薬業界における最新の技術開発を掘り下げることができます。これには、月経困難症治療技術の進歩、月経困難症治療の新規参入、月経困難症治療の新規投資、月経困難症治療の将来を形作るその他の技術革新が含まれます。 川下の事業者の好み:当レポートは、月経困難症治療市場における顧客の購買行動と採用傾向に光を当てることができます。顧客の購買決定、月経困難症治療製品の嗜好に影響を与える要因も含まれます。 政府の政策とインセンティブこの調査レポートは、政府の政策やインセンティブが月経困難症治療薬市場に与える影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、その他月経困難症治療薬市場の促進を目的とした施策の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。 環境への影響と持続可能性当調査レポートでは、月経困難症治療薬市場の環境への影響と持続可能性の側面を評価します。 市場予測と将来展望:調査レポートは、実施した分析に基づいて、月経困難症治療薬産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会:本レポートは、業界関係者、政策立案者、投資家への提言で締めくくります。市場関係者が新たなトレンドを活用し、課題を克服し、月経困難症治療薬市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場の細分化 月経困難症治療薬市場は、タイプ別と用途別に分類されます。2019年から2030年までの期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を提供します。 タイプ別セグメント 鎮痛剤 ホルモン療法 外科手術 用途別セグメント 病院 クリニック 研究センター その他 本レポートは地域別にも市場を分割しています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、一次専門家から収集したインプットと、企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 メルク社 ノバルティスAG バイエル アボット・ラボラトリーズ ファイザー ロシュ TAJファーマ マイラン製薬 ノーベル製薬 ジュニパー・ファーマシューティカルズ サノフィ グラクソ・スミスクライン ジョンソン・エンド・ジョンソン フォーカスコンシューマーヘルスケア 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Dysmenorrhea Treatment Market Size 2019-2030 2.1.2 Dysmenorrhea Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Dysmenorrhea Treatment Segment by Type 2.2.1 Pain Relievers 2.2.2 Hormonal Therapy 2.2.3 Surgery 2.3 Dysmenorrhea Treatment Market Size by Type 2.3.1 Dysmenorrhea Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Dysmenorrhea Treatment Market Size Market Share by Type (2019-2024) 2.4 Dysmenorrhea Treatment Segment by Application 2.4.1 Hospitals 2.4.2 Clinics 2.4.3 Research Centers 2.4.4 Others 2.5 Dysmenorrhea Treatment Market Size by Application 2.5.1 Dysmenorrhea Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Dysmenorrhea Treatment Market Size Market Share by Application (2019-2024) 3 Dysmenorrhea Treatment Market Size by Player 3.1 Dysmenorrhea Treatment Market Size Market Share by Players 3.1.1 Global Dysmenorrhea Treatment Revenue by Players (2019-2024) 3.1.2 Global Dysmenorrhea Treatment Revenue Market Share by Players (2019-2024) 3.2 Global Dysmenorrhea Treatment Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Dysmenorrhea Treatment by Regions 4.1 Dysmenorrhea Treatment Market Size by Regions (2019-2024) 4.2 Americas Dysmenorrhea Treatment Market Size Growth (2019-2024) 4.3 APAC Dysmenorrhea Treatment Market Size Growth (2019-2024) 4.4 Europe Dysmenorrhea Treatment Market Size Growth (2019-2024) 4.5 Middle East & Africa Dysmenorrhea Treatment Market Size Growth (2019-2024) 5 Americas 5.1 Americas Dysmenorrhea Treatment Market Size by Country (2019-2024) 5.2 Americas Dysmenorrhea Treatment Market Size by Type (2019-2024) 5.3 Americas Dysmenorrhea Treatment Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Dysmenorrhea Treatment Market Size by Region (2019-2024) 6.2 APAC Dysmenorrhea Treatment Market Size by Type (2019-2024) 6.3 APAC Dysmenorrhea Treatment Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Dysmenorrhea Treatment by Country (2019-2024) 7.2 Europe Dysmenorrhea Treatment Market Size by Type (2019-2024) 7.3 Europe Dysmenorrhea Treatment Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Dysmenorrhea Treatment by Region (2019-2024) 8.2 Middle East & Africa Dysmenorrhea Treatment Market Size by Type (2019-2024) 8.3 Middle East & Africa Dysmenorrhea Treatment Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Dysmenorrhea Treatment Market Forecast 10.1 Global Dysmenorrhea Treatment Forecast by Regions (2025-2030) 10.1.1 Global Dysmenorrhea Treatment Forecast by Regions (2025-2030) 10.1.2 Americas Dysmenorrhea Treatment Forecast 10.1.3 APAC Dysmenorrhea Treatment Forecast 10.1.4 Europe Dysmenorrhea Treatment Forecast 10.1.5 Middle East & Africa Dysmenorrhea Treatment Forecast 10.2 Americas Dysmenorrhea Treatment Forecast by Country (2025-2030) 10.2.1 United States Dysmenorrhea Treatment Market Forecast 10.2.2 Canada Dysmenorrhea Treatment Market Forecast 10.2.3 Mexico Dysmenorrhea Treatment Market Forecast 10.2.4 Brazil Dysmenorrhea Treatment Market Forecast 10.3 APAC Dysmenorrhea Treatment Forecast by Region (2025-2030) 10.3.1 China Dysmenorrhea Treatment Market Forecast 10.3.2 Japan Dysmenorrhea Treatment Market Forecast 10.3.3 Korea Dysmenorrhea Treatment Market Forecast 10.3.4 Southeast Asia Dysmenorrhea Treatment Market Forecast 10.3.5 India Dysmenorrhea Treatment Market Forecast 10.3.6 Australia Dysmenorrhea Treatment Market Forecast 10.4 Europe Dysmenorrhea Treatment Forecast by Country (2025-2030) 10.4.1 Germany Dysmenorrhea Treatment Market Forecast 10.4.2 France Dysmenorrhea Treatment Market Forecast 10.4.3 UK Dysmenorrhea Treatment Market Forecast 10.4.4 Italy Dysmenorrhea Treatment Market Forecast 10.4.5 Russia Dysmenorrhea Treatment Market Forecast 10.5 Middle East & Africa Dysmenorrhea Treatment Forecast by Region (2025-2030) 10.5.1 Egypt Dysmenorrhea Treatment Market Forecast 10.5.2 South Africa Dysmenorrhea Treatment Market Forecast 10.5.3 Israel Dysmenorrhea Treatment Market Forecast 10.5.4 Turkey Dysmenorrhea Treatment Market Forecast 10.5.5 GCC Countries Dysmenorrhea Treatment Market Forecast 10.6 Global Dysmenorrhea Treatment Forecast by Type (2025-2030) 10.7 Global Dysmenorrhea Treatment Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Merck & Co. 11.1.1 Merck & Co. Company Information 11.1.2 Merck & Co. Dysmenorrhea Treatment Product Offered 11.1.3 Merck & Co. Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Merck & Co. Main Business Overview 11.1.5 Merck & Co. Latest Developments 11.2 Novartis AG 11.2.1 Novartis AG Company Information 11.2.2 Novartis AG Dysmenorrhea Treatment Product Offered 11.2.3 Novartis AG Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Novartis AG Main Business Overview 11.2.5 Novartis AG Latest Developments 11.3 Bayer 11.3.1 Bayer Company Information 11.3.2 Bayer Dysmenorrhea Treatment Product Offered 11.3.3 Bayer Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Bayer Main Business Overview 11.3.5 Bayer Latest Developments 11.4 Abbott Laboratories 11.4.1 Abbott Laboratories Company Information 11.4.2 Abbott Laboratories Dysmenorrhea Treatment Product Offered 11.4.3 Abbott Laboratories Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Abbott Laboratories Main Business Overview 11.4.5 Abbott Laboratories Latest Developments 11.5 Pfizer 11.5.1 Pfizer Company Information 11.5.2 Pfizer Dysmenorrhea Treatment Product Offered 11.5.3 Pfizer Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Pfizer Main Business Overview 11.5.5 Pfizer Latest Developments 11.6 Roche 11.6.1 Roche Company Information 11.6.2 Roche Dysmenorrhea Treatment Product Offered 11.6.3 Roche Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Roche Main Business Overview 11.6.5 Roche Latest Developments 11.7 TAJ Pharma 11.7.1 TAJ Pharma Company Information 11.7.2 TAJ Pharma Dysmenorrhea Treatment Product Offered 11.7.3 TAJ Pharma Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 TAJ Pharma Main Business Overview 11.7.5 TAJ Pharma Latest Developments 11.8 Mylan Pharmaceuticals 11.8.1 Mylan Pharmaceuticals Company Information 11.8.2 Mylan Pharmaceuticals Dysmenorrhea Treatment Product Offered 11.8.3 Mylan Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Mylan Pharmaceuticals Main Business Overview 11.8.5 Mylan Pharmaceuticals Latest Developments 11.9 Nobel Pharmaceuticals 11.9.1 Nobel Pharmaceuticals Company Information 11.9.2 Nobel Pharmaceuticals Dysmenorrhea Treatment Product Offered 11.9.3 Nobel Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Nobel Pharmaceuticals Main Business Overview 11.9.5 Nobel Pharmaceuticals Latest Developments 11.10 Juniper Pharmaceuticals 11.10.1 Juniper Pharmaceuticals Company Information 11.10.2 Juniper Pharmaceuticals Dysmenorrhea Treatment Product Offered 11.10.3 Juniper Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Juniper Pharmaceuticals Main Business Overview 11.10.5 Juniper Pharmaceuticals Latest Developments 11.11 Sanofi 11.11.1 Sanofi Company Information 11.11.2 Sanofi Dysmenorrhea Treatment Product Offered 11.11.3 Sanofi Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 Sanofi Main Business Overview 11.11.5 Sanofi Latest Developments 11.12 GlaxoSmithKline 11.12.1 GlaxoSmithKline Company Information 11.12.2 GlaxoSmithKline Dysmenorrhea Treatment Product Offered 11.12.3 GlaxoSmithKline Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 GlaxoSmithKline Main Business Overview 11.12.5 GlaxoSmithKline Latest Developments 11.13 Johnson & Johnson 11.13.1 Johnson & Johnson Company Information 11.13.2 Johnson & Johnson Dysmenorrhea Treatment Product Offered 11.13.3 Johnson & Johnson Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 Johnson & Johnson Main Business Overview 11.13.5 Johnson & Johnson Latest Developments 11.14 Focus Consumer Healthcare 11.14.1 Focus Consumer Healthcare Company Information 11.14.2 Focus Consumer Healthcare Dysmenorrhea Treatment Product Offered 11.14.3 Focus Consumer Healthcare Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 Focus Consumer Healthcare Main Business Overview 11.14.5 Focus Consumer Healthcare Latest Developments 12 Research Findings and Conclusion
SummaryAccording to our LPI (LP Information) latest study, the global Dysmenorrhea Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Dysmenorrhea Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Dysmenorrhea Treatment Market Size 2019-2030 2.1.2 Dysmenorrhea Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Dysmenorrhea Treatment Segment by Type 2.2.1 Pain Relievers 2.2.2 Hormonal Therapy 2.2.3 Surgery 2.3 Dysmenorrhea Treatment Market Size by Type 2.3.1 Dysmenorrhea Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Dysmenorrhea Treatment Market Size Market Share by Type (2019-2024) 2.4 Dysmenorrhea Treatment Segment by Application 2.4.1 Hospitals 2.4.2 Clinics 2.4.3 Research Centers 2.4.4 Others 2.5 Dysmenorrhea Treatment Market Size by Application 2.5.1 Dysmenorrhea Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Dysmenorrhea Treatment Market Size Market Share by Application (2019-2024) 3 Dysmenorrhea Treatment Market Size by Player 3.1 Dysmenorrhea Treatment Market Size Market Share by Players 3.1.1 Global Dysmenorrhea Treatment Revenue by Players (2019-2024) 3.1.2 Global Dysmenorrhea Treatment Revenue Market Share by Players (2019-2024) 3.2 Global Dysmenorrhea Treatment Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Dysmenorrhea Treatment by Regions 4.1 Dysmenorrhea Treatment Market Size by Regions (2019-2024) 4.2 Americas Dysmenorrhea Treatment Market Size Growth (2019-2024) 4.3 APAC Dysmenorrhea Treatment Market Size Growth (2019-2024) 4.4 Europe Dysmenorrhea Treatment Market Size Growth (2019-2024) 4.5 Middle East & Africa Dysmenorrhea Treatment Market Size Growth (2019-2024) 5 Americas 5.1 Americas Dysmenorrhea Treatment Market Size by Country (2019-2024) 5.2 Americas Dysmenorrhea Treatment Market Size by Type (2019-2024) 5.3 Americas Dysmenorrhea Treatment Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Dysmenorrhea Treatment Market Size by Region (2019-2024) 6.2 APAC Dysmenorrhea Treatment Market Size by Type (2019-2024) 6.3 APAC Dysmenorrhea Treatment Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Dysmenorrhea Treatment by Country (2019-2024) 7.2 Europe Dysmenorrhea Treatment Market Size by Type (2019-2024) 7.3 Europe Dysmenorrhea Treatment Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Dysmenorrhea Treatment by Region (2019-2024) 8.2 Middle East & Africa Dysmenorrhea Treatment Market Size by Type (2019-2024) 8.3 Middle East & Africa Dysmenorrhea Treatment Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Dysmenorrhea Treatment Market Forecast 10.1 Global Dysmenorrhea Treatment Forecast by Regions (2025-2030) 10.1.1 Global Dysmenorrhea Treatment Forecast by Regions (2025-2030) 10.1.2 Americas Dysmenorrhea Treatment Forecast 10.1.3 APAC Dysmenorrhea Treatment Forecast 10.1.4 Europe Dysmenorrhea Treatment Forecast 10.1.5 Middle East & Africa Dysmenorrhea Treatment Forecast 10.2 Americas Dysmenorrhea Treatment Forecast by Country (2025-2030) 10.2.1 United States Dysmenorrhea Treatment Market Forecast 10.2.2 Canada Dysmenorrhea Treatment Market Forecast 10.2.3 Mexico Dysmenorrhea Treatment Market Forecast 10.2.4 Brazil Dysmenorrhea Treatment Market Forecast 10.3 APAC Dysmenorrhea Treatment Forecast by Region (2025-2030) 10.3.1 China Dysmenorrhea Treatment Market Forecast 10.3.2 Japan Dysmenorrhea Treatment Market Forecast 10.3.3 Korea Dysmenorrhea Treatment Market Forecast 10.3.4 Southeast Asia Dysmenorrhea Treatment Market Forecast 10.3.5 India Dysmenorrhea Treatment Market Forecast 10.3.6 Australia Dysmenorrhea Treatment Market Forecast 10.4 Europe Dysmenorrhea Treatment Forecast by Country (2025-2030) 10.4.1 Germany Dysmenorrhea Treatment Market Forecast 10.4.2 France Dysmenorrhea Treatment Market Forecast 10.4.3 UK Dysmenorrhea Treatment Market Forecast 10.4.4 Italy Dysmenorrhea Treatment Market Forecast 10.4.5 Russia Dysmenorrhea Treatment Market Forecast 10.5 Middle East & Africa Dysmenorrhea Treatment Forecast by Region (2025-2030) 10.5.1 Egypt Dysmenorrhea Treatment Market Forecast 10.5.2 South Africa Dysmenorrhea Treatment Market Forecast 10.5.3 Israel Dysmenorrhea Treatment Market Forecast 10.5.4 Turkey Dysmenorrhea Treatment Market Forecast 10.5.5 GCC Countries Dysmenorrhea Treatment Market Forecast 10.6 Global Dysmenorrhea Treatment Forecast by Type (2025-2030) 10.7 Global Dysmenorrhea Treatment Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Merck & Co. 11.1.1 Merck & Co. Company Information 11.1.2 Merck & Co. Dysmenorrhea Treatment Product Offered 11.1.3 Merck & Co. Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Merck & Co. Main Business Overview 11.1.5 Merck & Co. Latest Developments 11.2 Novartis AG 11.2.1 Novartis AG Company Information 11.2.2 Novartis AG Dysmenorrhea Treatment Product Offered 11.2.3 Novartis AG Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Novartis AG Main Business Overview 11.2.5 Novartis AG Latest Developments 11.3 Bayer 11.3.1 Bayer Company Information 11.3.2 Bayer Dysmenorrhea Treatment Product Offered 11.3.3 Bayer Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Bayer Main Business Overview 11.3.5 Bayer Latest Developments 11.4 Abbott Laboratories 11.4.1 Abbott Laboratories Company Information 11.4.2 Abbott Laboratories Dysmenorrhea Treatment Product Offered 11.4.3 Abbott Laboratories Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Abbott Laboratories Main Business Overview 11.4.5 Abbott Laboratories Latest Developments 11.5 Pfizer 11.5.1 Pfizer Company Information 11.5.2 Pfizer Dysmenorrhea Treatment Product Offered 11.5.3 Pfizer Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Pfizer Main Business Overview 11.5.5 Pfizer Latest Developments 11.6 Roche 11.6.1 Roche Company Information 11.6.2 Roche Dysmenorrhea Treatment Product Offered 11.6.3 Roche Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Roche Main Business Overview 11.6.5 Roche Latest Developments 11.7 TAJ Pharma 11.7.1 TAJ Pharma Company Information 11.7.2 TAJ Pharma Dysmenorrhea Treatment Product Offered 11.7.3 TAJ Pharma Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 TAJ Pharma Main Business Overview 11.7.5 TAJ Pharma Latest Developments 11.8 Mylan Pharmaceuticals 11.8.1 Mylan Pharmaceuticals Company Information 11.8.2 Mylan Pharmaceuticals Dysmenorrhea Treatment Product Offered 11.8.3 Mylan Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Mylan Pharmaceuticals Main Business Overview 11.8.5 Mylan Pharmaceuticals Latest Developments 11.9 Nobel Pharmaceuticals 11.9.1 Nobel Pharmaceuticals Company Information 11.9.2 Nobel Pharmaceuticals Dysmenorrhea Treatment Product Offered 11.9.3 Nobel Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Nobel Pharmaceuticals Main Business Overview 11.9.5 Nobel Pharmaceuticals Latest Developments 11.10 Juniper Pharmaceuticals 11.10.1 Juniper Pharmaceuticals Company Information 11.10.2 Juniper Pharmaceuticals Dysmenorrhea Treatment Product Offered 11.10.3 Juniper Pharmaceuticals Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Juniper Pharmaceuticals Main Business Overview 11.10.5 Juniper Pharmaceuticals Latest Developments 11.11 Sanofi 11.11.1 Sanofi Company Information 11.11.2 Sanofi Dysmenorrhea Treatment Product Offered 11.11.3 Sanofi Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 Sanofi Main Business Overview 11.11.5 Sanofi Latest Developments 11.12 GlaxoSmithKline 11.12.1 GlaxoSmithKline Company Information 11.12.2 GlaxoSmithKline Dysmenorrhea Treatment Product Offered 11.12.3 GlaxoSmithKline Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 GlaxoSmithKline Main Business Overview 11.12.5 GlaxoSmithKline Latest Developments 11.13 Johnson & Johnson 11.13.1 Johnson & Johnson Company Information 11.13.2 Johnson & Johnson Dysmenorrhea Treatment Product Offered 11.13.3 Johnson & Johnson Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 Johnson & Johnson Main Business Overview 11.13.5 Johnson & Johnson Latest Developments 11.14 Focus Consumer Healthcare 11.14.1 Focus Consumer Healthcare Company Information 11.14.2 Focus Consumer Healthcare Dysmenorrhea Treatment Product Offered 11.14.3 Focus Consumer Healthcare Dysmenorrhea Treatment Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 Focus Consumer Healthcare Main Business Overview 11.14.5 Focus Consumer Healthcare Latest Developments 12 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
LP Information社の医療分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|